InvestorsHub Logo

Cool888

11/27/20 5:56 PM

#17571 RE: bostrom #17564

Here you go...........

Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price
Aug 10/20 Aug 5/20 Frank, Michael Direct Ownership Options 50 - Grant of options 6,000,000 $0.330

ReikoBlack

11/27/20 5:57 PM

#17572 RE: bostrom #17564

Because, there's no need to make any 'buy' on the open market when they receive 'Options'.

In August of this year, Michael Frank was granted 6 million stock options, exercisable at $.33 until August, 2025.

"Revive would also like to announce that it has granted 6,000,000 stock options to an officer and director. Each option is exercisable at $0.33 per common share at any time until August 5, 2025"
https://www.globenewswire.com/news-release/2020/08/11/2076419/0/en/Revive-Therapeutics-Advancing-Drug-Delivery-Technology-for-Psychedelics.html

Why haven't Insiders bought shares of the company?

That is something I have worried about, you would think they knew the potential and would be buying. Come on Michael Frank, show us that you believe Not much buying from Insiders. Been over 1 year

Pennsy

11/27/20 6:43 PM

#17577 RE: bostrom #17564

Oh, how did you arrive at that assessment. How can one derive who is buying shares. Not familiar with that technique.